71 results about "Thrombophlebitis" patented technology

A lower limb function training device which the user themselves can use safely with no sense of fear, which is used to prevent thrombophlebitis known as economy syndrome, which allows the user to select the type of exercise, and which enables to train own lower limbs in the narrow area is provided with a foot rest bar (501), in which both the feet are put on, a supporting structure (502) of the foot rest bar that has repulsive force which can be extended, a storage device (503) of said supporting structure and said foot rest bar, a pivot axis (504) of which load device (507) which enable to set the device to detect the number of times, speed to move and brake is mounted and a set up structure (506) for the supporting structure of the foot rest bar to a case (505).

The invention discloses a traditional Chinese medicine composition for treating thrombophlebitis. The invention also discloses a preparation method of the traditional Chinese medicine composition. The preparation method of the traditional Chinese medicine composition comprises the following steps: taking three kinds of animal class medicinal powder of leech, centipede and scorpio which are processed by a superfine pulverization technique and have the average particle diameter smaller than the fineness of 75mum and medicinal materials of which volatile oil is extracted, adding water firstly, extracting the volatile oil, taking the medicinal materials after extracting the volatile oil and other medicinal materials which are extracted by using the water, adding the water, decocting, extracting, and preparing water extractive paste by a water extract through filtration, concentration, ethanol transfer dissolution and concentration.

The invention provides a traditional Chinese medicine composition for treating thrombophlebitis, composed of a medicine for oral administration, a medicine for external washing and a medicine for external application, wherein the medicine for oral administration contains angelica sinensis, red peony root, red flower, saffron crocus, salviae miltiorrhizae, radix achyranthis bidentatae, rhizoma atractylodis, poria cocos, caulis lonicerae, fructus kochiae, dittany bark, golden cypress, liquidambar formosana hance, coix lachryma-jobi kernel, liquorice, mulberry twig and cooked pangolin scales; the medicine for external washing contains liquidambar formosana hance, golden cypress, coix lachryma-jobi kernel, pawpaw, red flower, radix achyranthis bidentatae, red peony root, gleditsia sinensis sting, dittany bark, liquorice, divaricate saposhnikovia root and rheum officinale; and the medicine for external application contains the following components equal in proportion: shell powder, edible zinc powder, dragon's blood and wolfberry. Compared with the prior art, the traditional Chinese medicine composition provided by the invention has a special curative effect for thrombophlebitis in a treatment way of oral administration and external application of the medicine for oral administration, the medicine for external washing and the medicine for external application; and the curative effect of the composition is clinically verified yet.

The invention discloses a method for extracting hirudin by electrically stimulating living leeches. The method includes four steps of extraction of secretion, preparation of protectant, processing of secretion and drying of secretion. The product dry powder contains the main effectively active ingredient, namely hirudin, extracted from the living leeches, which can be used for preventing and treating vein thrombosis, disseminated intravascular coagulation, brain coagulation, thrombophlebitis, coronary thrombosis and the like. Compared with the prior art, the method has the advantages that hirudin production process is simplified while living leeches are maintained for extracting high-purity hirudin multiple times.

The invention relates to a decoction medicine for treating thrombophlebitis and a preparation method for the decoction medicine. The medicine comprises the following components in parts by mass: 1 to 3 parts of caulis lonicerae, 1 to 3 parts of scrophularia, 1 to 3 parts of angelica sinensis, 1 to 3 parts of ligusticum wallichii, 1 to 3 parts of red paeony root, 1 to 3 parts of peach seed, 1 to 3 parts of carthamus tinctorius, 1 to 3 parts of achyranthes bidentata, 1 to 3 parts of sinomenium acutum, 1 to 3 parts of clematis root, 1 to 3 parts of caulis sinomenii and 1 to 3 parts of liquorice. The preparation method for the medicine comprises the following steps: selecting and purchasing high-quality and clean first-grade caulis lonicerae, scrophularia, angelica sinensis, ligusticum wallichii, red paeony root, peach seed, carthamus tinctorius, achyranthes bidentata, sinomenium acutum, clematis root, caulis sinomenii and liquorice in parts by mass; respectively removing impurities and dust, and putting the components into a cloth bag and tying the bag for later use; soaking the medicines into cooled boiled water for about half a hour until the cooled boiled water permeates medicine tissues; then, placing the soaked medicines and the clear liquid into which the medicines are soaked into a medicine decocting machine; adding cooled boiled water to immerse the medicines by 33 mm and decocting 30 minutes for the first time; filtering medicine liquid; then, adding lukewarm boiled water to immerse the medicines by 28 mm and decocting 25 minutes for the second time; mixing and concentrating to obtain 1,710 milliliter of 50 percent traditional Chinese medicine liquid.

The invention relates to a traditional Chinese medicine composition fro treating thrombophlebitis. The traditional Chinese medicine is prepared by the following raw materials by weight part: 25-32g of astragalus mongholicus, 12-17g of codonopsis pilosula, 13-17g of angelica sinensis, 14-16g of ligusticum wallichii, 13-17g of spina gleditsiae, 14-17g of root of common peony, 8-11g of elecampane, 9-12g of akebiaquinata, 7-11g of manis pentadactyla, 9-11g of rheum officinale and 18-22g of honeysuckle stem. According to the traditional Chinese medicine composition, the traditional Chinese medicines are selected and matched with each other, and the characteristics of the medicines can be fully utilized, so that the traditional Chinese medicine composition relieves rigidity of muscles and activates collaterals, promotes blood circulation to remove blood stasis, dissolves phlegm and removes stasis, and has obvious effects on the treatment of thrombophlebitis.

The invention discloses a traditional Chinese medicine composition for treating thrombophlebitis, and a preparation method thereof, and belongs to the technical field of traditional Chinese medicines. The traditional Chinese medicine composition is composed of the following raw materials by weight: 10-20 parts of poria, 10-15 parts of white atractylodes rhizome, 5-15 parts of radix codonopsis, 20-30 parts of radix astragali, 15-20 parts of Chinese angelica root, 10-20 parts of red peony root, 5-15 parts of peach kernels, 5-15 parts of safflower, 5-15 parts of sappanwood, 10-20 parts of cassia twig, 15-20 parts of honeysuckle, 10-20 parts of rhizoma corydalis and 10-20 parts of melia toosendan. On basis of a theory of traditional Chinese medicine, the traditional Chinese medicine composition combines a formula according to a sovereign, minister, assistant and envoy principle. In the formula, the poria, radix codonopsis and safflower are used as sovereign drugs which have the function of activating blood to resolve stasis; the honeysuckle, rhizoma corydalis and melia toosenedan are used as minister drugs which have the function of regulating lipid; and the red peony root, peach kernels and cassia twig are used as envoy drugs which have the functions of coordinating all the drugs, dispersing swelling and enhancing immunity of a patient. The traditional Chinese medicine composition is mainly used for treating the thrombophlebitis, particularly for sore symptoms of a thrombophlebitis patient, and has a definite curative effect.

The invention provides a pharmaceutical composition for treating cardiovascular and cerebrovascular diseases, its preparing process and quality control method, wherein Troxerutin and one or two of ligustilides and Ligusticum wallichii alkaloids are employed in combination to obtain various dose forms of injections and oral administration preparations. The composite preparation is mainly used for treating coronary disease, angina pectoris, cerebrovascular disease, pulmonary heart disease, thrombotic phlebitis, capillary vessel hemorrhage and hypertension.

An injection of troxerutin for treating obliterative syndrome, thrombophlebitis, capillary hemorrhage is prepared through ion exchange of troxerutin, mixing with the water for injection, pouring in containers, sterilizing, and lamp examining.

The invention discloses a drug for treating thrombophlebitis and a preparation method thereof. The drug comprises the following raw materials: coix seed, sargentodoxa cuneata, red sage root, rhizoma sparganii, red yeast rice, smilax perfoliata, salted phellodendron, earthworm, Chinese violet, evodia lepta, sansevieria, euphorbia humifusa, Indian rorippa herb, rhaphidophora decursiva, buck grass, madder, caesalpinia sappan, smilax glabra, sticktight, anemarrhena, large-leaved gentian, stephania tetrandra, floating pondweed, juncus effuses, ipomoea aquatic, phlomis umbrosa, glechoma longituba, fructus malvae vertillatae, fiveleaf akebia fruit, fried atractylodes, radix aristolochiae, katsumade galangal seed, ground beetle, and talcum. The drug is prepared by scientifically compounding traditional Chinese herbals with different pharmaceutical properties, has the functions of clearing heat, removing dampness, freeing collaterals, diffusing impediment, purging fire, removing toxicity, relieving pains, activating functional activities of qi, regulating qi, and harmonizing stomach, treats both the root and the symptoms, can safely and effectively treat the thrombophlebitis in a short time, moreover, the manufacturing technology is simple and convenient, the cost is low, and the relapse is difficult after healing.

A medicinal composition for treating cerebrovascular diseases, craniocerebral trauma, cerebral disfunction, arteriosclerosis, thrombophlebitis, etc is prepared from 7,3',4'-trihydroxyethyl rutin and the liquid extract of the brain of mammal except man.

The invention pertains to the medicine technology field, which discloses a combination of gross safflor yellow which is safflower effective parts and total flavonoids of glycyrrhiza which is licorice effective parts and the application thereof. The invention is characterized in that the invention consists of gross safflor yellow, total flavonoids of glycyrrhiza and appropriate pharmaceutical excipients and is prepared into various formulations that are acceptable in pharmaceutics and have the effects of curing various vascular inflammation diseases, such as solid preparation, injection preparation and external gel, etc. Two effective parts in the invention are used together, which has distinctive synergy effect and has distinctive effects on diseases such as phlebitis caused by venipuncture, thrombophlebitis and thromboangiitis obliterans. Compared with the similar medicines of the market, the invention has the advantages of high security and better effect.

The invention discloses a traditional Chinese medicinal composition for treating acute phase thrombophlebitis. Aiming at the clinical pathogenesis of acute phase thrombophlebitis, the traditional Chinese medicinal composition is prepared into decoction by decocting the following traditional Chinese medicines, namely, barleria lupulina, tinospora sinensis, gendarussa nees, the stem of falsenettleleaf pepper, campylotropis macrocarpa, large-leaved uncaria root, peltateleaf begonia herb and rhizome, cyclosorus dentatus, root of ixora chinensis lam, root of doellingeria scaber, scarlet kadsura root and henry clematis root, which have the effects of clearing heat and promoting diuresis, promoting blood circulation and removing stasis, and clearing and activating the channels and collaterals. Through a clinical trial, the total effective rate is 94.44 percent.

The invention relates to a pharmaceutical composition comprising 2,5-dihydroxybenzenesulfonic acid or a pharmaceutically acceptable salt thereof in the form of personalised supply units and a corresponding manufacturing method. The pharmaceutical composition comprising 2,5-dihydroxybenzenesulfonic acid or a pharmaceutically acceptable salt thereof in the form of personalised supply units, in which part of the 2,5-dihydroxybenzenesulfonic acid is in the form of an immediate-release composition additionally comprising between 8% and 28% microcrystalline cellulose, and the other part of which is in the form of a prolonged-release composition additionally comprising between 10% and 45% hydroxypropylmethylcellulose and between 6.1% and 20% hydroxypropylcellulose. The proportion between the two parts is between 24:76 and 40:60. This allows administration of the composition to the patient once every 24 hours. The composition can be used to treat primary varicose states, chronic venous insufficiency, phlebitis, thrombophlebitis, post-thrombotic syndrome, leg ulcers, pregnancy-related varicose veins. as a coadjuvant for varicectomy, sclerotherapy or as a coadjuvant in the treatment of diabetic retinopathy.

The invention relates to a troxerutin sustained-release drop pill for the treatment of hemiplegia, aphasia, arteriosclerosis, central retinitis, thrombophlebitis, varicose veins and other symptoms caused by cerebral thrombosis and cerebral embolism, as well as a preparation method thereof. The invention aims at utilizing the sustained-release pharmaceutical technology to make up for the shortcomings of the prior art and providing the troxerutin sustained-release drop pill with high bioavailability, few administration times, long-term effect, no toxicity, no side effects and convenient usage and carrying, as well as the preparation method thereof. The troxerutin is taken as raw material, a hydrophilic skeleton material and a hydrophobic skeleton material are added according to certain weight percentages to be taken as matrixes and evenly mixed, the mixed materials are heated till melting, evenly stirred and arranged in a special pill dropping machine, and then dropped into condensate liquid at appropriate speed for preparation.

The invention discloses a traditional Chinese medicine preparation for treating lower limb thrombophlebitis and belongs to the technical field of traditional Chinese medicines. Aiming at the cause of the formation of lower limb thrombophlebitis, the inventor selects traditional Chinese medicines including muskroot-like semiaquilegia root, blumea lacera, hairy holly leaf, roughhaired holly root, saussurea pulchra, Toddalia asiatica (L.) Lam., berchemia sinica, oenothera biennis, nothapodytes pittosporoids, sambucus buergeriana, largeleaf dogwood bark and viburnum sargenti with effects of clearing heat and promoting diuresis, promoting blood circulation and removing stasis and dredging meridians and collaterals, and decocts the traditional Chinese medicines in water to obtain decoction, and according to clinical tests, the total effective rate reaches 93.3 percent.

The invention discloses a drug for treating deficiency-cold type thrombophlebitis and a preparation method thereof, wherein the drug is prepared from the following raw medicinal materials: skyblue broomrape herb, semen cuscutae, polygonum multiflorum, freshwater sponge, cinnamon, lamiophlomis rotate, sargentodoxa cuneata, lycopodium clavatum, trigone, hematoxylon, siberian walking fern, coleseed, sambucus chinensis, saffron crocus, hairyshoot elm bark, radix zanthoxyli, purslane speedwell herb, evergreen mucuna root and leaf, curcuma zedoary, ligusticum wallichii, red peony root, common achyranthes herb, lac, radix angelicae tuhuo, evodia rutaecarpa, benzoin, loquat core, neroli, lathyrus davidii, lindera aggregate, trifoliate orange, buckeye and licorice. The drug disclosed by the invention has the beneficial effects that, the drug has the functions of warming yang to restore normal collateral, promoting blood circulation to remove blood stasis, diminishing inflammation, stopping pain, soothing liver and regulating qi, is safe and effective when used for treating the deficiency-cold type thrombophlebitis and is short in cure time, traditional Chinese medicinal materials with different drug properties are scientifically matched, the preparation process of the drug is simple and convenient, the cost is low, and recurrence can be avoided after curing.

The invention provides a pharmaceutical composition for treating cardiovascular and cerebrovascular diseases, its preparing process and quality control method, wherein Troxerutin and one or several of Chinese angelica polysaccharides, Chinese angelica organic acids and Chinese angelica volatile oil to obtain various dose forms of injections and oral administration preparations. The composite preparation is mainly used for treating coronary disease, angina pectoris, arrhythmia, cerebral thrombus, apoplexy, thrombotic phlebitis and capillary vessel hemorrhage.

The invention relates to a method for preventing adhesion and avoiding thrombophlebitis, the method is designed aiming at medical materials of polymer medical glucosamine, in particular to chitin; the method provides the structural characteristics of anti-adhesion materials, biological performance requirements on surgical anti-adhesion and an assessment method of a safety test for preventing adverse reactions of the thrombophlebitis for the medical materials, avoids the damages on visual and auditory organs caused by the thrombophlebitis due to the blind use of glucosamine molecules with macromolecules and high degree of deacetylation and even avoids the occurrence of blood clotting in capillary vessels.

The invention discloses a Chinese medicinal composition for treating venation diseases and a preparation method thereof, and belongs to the field of traditional Chinese medicine treatment of the venation diseases. The invention firstly discloses the Chinese medicinal composition for treating the venation diseases, which is prepared from the following components: garden balsam stem, Chinese parsnip root, rhizoma pleionis and coix seed. On the basis of the Chinese medicinal composition disclosed by the invention, raw material medicines of cortex lycii radicis and stem of noble dendrobium are further added, so that the Chinese medicinal composition has better effects of detoxifying and relieving pain and reducing swelling and removing stasis. A comparison result of a clinical curative effect proves that an obvious synergistic effect is taken between garden balsam stem, Chinese parsnip root, rhizoma pleionis and coix seed and cortex lycii radicis as well as stem of noble dendrobium, and a cure rate and a total effective rate of treatment of the venation diseases can be obviously improved. The Chinese medicinal composition disclosed by the invention is reasonable in compatibility, has no toxic or side effects, has an exact curative effect, and can be used for preparing a medicament for treating the venation diseases, such as thrombophlebitis, varicosity or angiitis and the like.

The invention discloses a traditional Chinese medicine composition for treating acute thrombophlebitis. Aiming at the clinical pathogenesis of the acute thrombophlebitis, the traditional Chinese medicine composition selects Chinese medicines such as Thymifoious Euphorbia Herb, BloodVine, peruvian groundcherry herb, Drymaria diandra Bl., lithospermum, Caesalpinia minax Hance, Kadsura longipedunculata Finet et Gagn., japanese creeper root and stem, Celastrus hypoleucus (Oliv.) Warb, and Heterohairy Monkshood root, and is decocted with water into decoction. Through clinical trials, the cure rate is 75.0%; the conspicuous effect rate is 19.4%, and the effective rate is 5.6%; the number of ineffective case is 0; and the total effective rate is 100%, and the curative effect is very significant.

The invention relates to an anti-coagulation medicine, in particular to a synthesized pentasaccharide compound, salt thereof, and a preparing method and medical application of the pentasaccharide compound. The pentasaccharide compound or acid or salt thereof in the ion form shown in the formula II (the formula can be seen in the description) is synthesized and has stronger anti-coagulation factorXa activity and a longer elimination half life compared with sodium sulfonate. The pentasaccharide compound can be used for preparing medicines for preventing and treating blood coagulation disorder related diseases such as deep venous thrombosis, thrombophlebitis, artery blockage caused by thrombosis or embolism and postoperative vein thrombosis or embolism.

The invention relates to traditional Chinese medicine paste for treating chemotherapeutic phlebitis of 2 level and 3 level and preparation. The traditional Chinese medicine paste is characterized in that the raw materials comprise the following components proportioning by weight: 15-20 parts of safflower, 15-20 parts of rhizoma ligustici wallichii, 15-20 parts of angelica, 15-20 parts of radix salviae miltiorrhizae, 15-20 parts of rhizoma zedoariae, 15-20 parts of giant knotweed and 15-20 parts of corydalis tuber. The preparation method of the traditional Chinese medicine paste for treating the phlebitis of 2 level and 3 level is characterized by comprising the following steps: taking each component medicine according to the weight mixture ratio, grinding into superfine powder, mixing evenly, adding the superfine powder into molten vaseline according to the proportion of 1:4-5, stirring and preparing the traditional Chinese medicine paste. The traditional Chinese medicine paste for treating the chemotherapeutic phlebitis of 2 level and 3 level has convenient application and no toxic or side effect and has the effects of promoting blood circulation, relieving the stasis of blood, decreasing swelling, alleviating pain, relieving peripheral vascular smooth muscle spasm, prompting the flow of blood, suppressing the release of substances causing inflammation and suppressing the proliferation of blood bud tissues; the traditional Chinese medicine paste for treating the chemotherapeutic phlebitis of 2 level and 3 level prevents the formation of angiosclerosis and thrombus class phlebitis and enhances the utilization rate of blood vessels. The functions of effectively treating the phlebitis of 2 level and preventing and treating the phlebitis of 3 level are achieved.

The invention relates to an anti-coagulation medicine, in particular to a synthesized pentasaccharide compound, salt thereof, and a preparing method and medical application of the pentasaccharide compound. The pentasaccharide compound or acid or salt thereof in the ion form shown in the formula III (the formula can be seen in the description) is synthesized and has stronger anti-coagulation factorXa activity and a longer elimination half life compared with sodium sulfonate. The pentasaccharide compound can be used for preparing medicines for preventing and treating blood coagulation disorderrelated diseases such as deep venous thrombosis, thrombophlebitis, artery blockage caused by thrombosis or embolism and postoperative vein thrombosis or embolism.